Nalaganje...
Oral Apremilast for the Treatment of Plaque Psoriasis
This article provides an update on the use of oral apremilast, a phosphodiesterase-4 (PDE4) inhibitor, for the treatment of plaque psoriasis. Emphasis is placed on safety evaluations, although efficacy considerations are also addressed. Both two-year and three -year data analyses support the favorab...
Shranjeno v:
| izdano v: | J Clin Aesthet Dermatol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Matrix Medical Communications
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5110328/ https://ncbi.nlm.nih.gov/pubmed/27878061 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|